These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7505351)

  • 21. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of dividing amlodipine daily doses on trough drug concentrations and blood pressure control over a 24-hour period.
    Miyoshi K; Okura T; Nagao T; Masanori J; Irita J; Higaki J
    Clin Ther; 2013 Sep; 35(9):1418-22. PubMed ID: 23972579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group.
    Wilson TW; Lacourcière Y; Barnes CC
    CMAJ; 1998 Sep; 159(5):469-76. PubMed ID: 9757170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Office and ambulatory blood pressure: a comparison between amlodipine and felodipine ER. Danish Multicentre Group.
    Høegholm A; Wiinberg N; Rasmussen E; Nielsen PE
    J Hum Hypertens; 1995 Aug; 9(8):611-6. PubMed ID: 8523374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parallel comparative trial of amlodipine and nitrendipine monotherapy in patients with essential hypertension.
    Wang X; Gong L; Guo J; Wang X; Liu Y; Ye X; Zhang G; Yang P
    J Hypertens Suppl; 1998 Sep; 16(4):S43-7. PubMed ID: 9817192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-pill combination of telmisartan/amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trial.
    Sharma AM; Bakris G; Neutel JM; Littlejohn TW; Kobe M; Ting N; Ley L
    Clin Ther; 2012 Mar; 34(3):537-51. PubMed ID: 22386829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized, controlled, parallel-group comparison of ambulatory and clinic blood pressure responses to amlodipine or enalapril during and after treatment in adult chinese patients with hypertension.
    Tomlinson B; Woo J; Thomas GN; Chau YM; Critchley JA
    Clin Ther; 2004 Aug; 26(8):1292-304. PubMed ID: 15476910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive effects of trandolapril and nitrendipine in the elderly: a controlled trial with special emphasis on time effect profiles.
    Zannad F; Vaur L; Dutrey-Dupagne C; Genes N; Clerson P
    J Hum Hypertens; 1996 Jan; 10(1):51-5. PubMed ID: 8642191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive efficacy of night-time graded-release diltiazem versus morning amlodipine in African Americans.
    Wright JT; Sica DA; Gana TJ; Bohannon K; Pascual LG; Albert KS
    Am J Hypertens; 2004 Sep; 17(9):734-42. PubMed ID: 15363813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effects of amlodipine and felodipine ER on office and ambulatory blood pressure in patients with mild to moderate hypertension. Danish Multicentre Group.
    Høegholm A; Wiinberg N; Rasmussen E; Nielsen PE
    J Hum Hypertens; 1995 Mar; 9 Suppl 1():S25-8. PubMed ID: 7783110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up, noninferiority trial.
    Hong SJ; Ahn TH; Baek SH; Cho WH; Jeon HK; Kwan J; Yoon MH; Lee KJ; Lim DS
    Clin Ther; 2006 Apr; 28(4):537-51. PubMed ID: 16750465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
    Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind evaluation of the dose-response relationship of amlodipine in essential hypertension.
    Mehta JL; Lopez LM; Vlachakis ND; Gradman AH; Nash DT; O'Connell MT; Garland WT; Pickering BI
    Am Heart J; 1993 Jun; 125(6):1704-10. PubMed ID: 8498314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitrendipine 20 mg once daily versus nicardipine slow release 40 mg twice daily in mild essential hypertension: evaluation by 24-hour ambulatory blood pressure monitoring.
    Fogari R; Tettamanti F; Zoppi A; Poletti L; Malamani GD; Corradi L; Borgnino C
    Clin Exp Hypertens A; 1992; 14(4):587-96. PubMed ID: 1628410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative study of spirapril (quadropril) and amlodipine efficacy. Results of randomized trial in patients with mild to moderate arterial hypertension].
    Shal'nova SA; Martsevich SIu; Deev AD; Kutishenko NP; Kukushkin SK; Manoshkina EM; Alimova EV; Semenova IuE; Lebedev AV; Koniakhina IP; Zagrebel'nyĭ AV
    Ter Arkh; 2000; 72(10):86-9. PubMed ID: 11220888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.